Home › Core › ISCC-IDs › 28Cr1Xt1PkFo5

View ISCC-ID

Core Data

28Cr1Xt1PkFo5
ISCC-ID - digital asset identifier
CCEWF1Swmiq6X-CTWQwywMcUWhf-CDhX3pMmjWnF8-CRPnHcCufTHqk
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

sparc promoter hypermethylation in colorectal cancers can be reversed by 5aza2deoxycytidine to increase sparc expression and imp

Ledger Reference

coblo
Source Ledger/Blockchain
12400305
N-th ISCC Decleration on source ledger
339fb29d25894ac197e24bdebb470236cc6a0f16263ee425c7f44f34f024fb2f
Hash of block that includes the ISCC-DECLARATION
79b706fdfdbf1740941f91d60019f4b37977b8cfd9af5c31f27ffa6d80ba0e9c
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2\u2032deoxycytidine to increase SPARC expression and improve therapy response", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "S Cheetham", "@type": "Person"}, {"name": "M J Tang", "@type": "Person"}, {"name": "F Mesak", "@type": "Person"}, {"name": "H Kennecke", "@type": "Person"}, {"name": "D Owen", "@type": "Person"}, {"name": "I T Tai", "@type": "Person"}], "license": "cc-by-nc-sa", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.nature.com/articles/6604377.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Science and Business Media LLC", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1038/sj.bjc.6604377", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCEWF1Swmiq6X-CTWQwywMcUWhf-CDhX3pMmjWnF8-CRPnHcCufTHqk", "propertyID": "ISCC"}], "datePublished": "2008-05-06"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close